London, UK (PRWEB) July 16, 2013
In the next five years, the worldwide hematology and cytometry industry is expected to experience a significant transformation due to the ongoing developments in molecular diagnostics, IT and laser technology, monoclonal antibodies (MAbs) along with an ever-increasing understanding of the immunologic factors which regulate systemic illnesses.
The ongoing changes in the global hematology and flow cytometry market are predicted to open up a host of opportunities for developing and introducing new devices and technologies.
New study “Hematology and Flow Cytometry: Granular Analysis of the Global Market Supplier Shares and Forecasts for over 40 Tests France, Germany, Italy, Japan, Spain, UK, US” created by Venture Planning Group (VPG) has been recently published by Market Publishers Ltd.
Title: Hematology and Flow Cytometry: Granular Analysis of the Global Market Supplier Shares and Forecasts for over 40 Tests France, Germany, Italy, Japan, Spain, UK, US
Published: July, 2013
Price: US$ 21,100.00
The datapack presents an in-depth analysis of the hematology and flow cytometry market performance globally, particularly focusing on such key countries as France, Germany, Italy, Japan, Spain, the UK and the USA. The study features market share analysis, test volume and sales forecasts for more than 40 tests, emerging industry opportunities, and granular market segmentation analysis. The competitive landscape overview along with vital details on the leading market participants is available in the research. In addition, detailed market outlook and forecast can also be found in the study.
The market segments covered include: hospitals, commercial/private laboratories and physician offices/group practices.
Reasons to Buy:
More new datapacks and other studies by the publisher can be found at VPG page.
Read the full story at http://www.prweb.com/releases/2013/7/prweb10932997.htm.
Copyright©2012 Vocus, Inc.
All rights reserved